Navigation Links
Thoratec Announces Appointment of Paul LaViolette to Board of Directors
Date:5/15/2009

PLEASANTON, Calif., May 15 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced the election of Paul A. LaViolette, the former chief operating officer of Boston Scientific, to its board of directors. LaViolette was elected by the company's shareholders at the company's annual shareholders' meeting on May 13 and brings the number of the company's directors to eight.

LaViolette spent 14 years at Boston Scientific and served as chief operating officer from 2004-2008. Before that, he was senior vice president and group president for several of the company's divisions and its international operations. He was formerly associated with C.R. Bard, Inc., where he held senior management positions and led several of the company's divisions.

"We are pleased to have someone with Paul's broad cardiovascular and medical device experience joining our board. His industry knowledge and successful track record of growing medical technology businesses will be of great value to Thoratec as we pursue our growth strategies," said Gary F. Burbach, president and chief executive officer of Thoratec.

"I also want to acknowledge the contributions of those directors who are stepping down. Dr. J. Donald Hill, a founder of the company and a director since its inception, is a pioneer in the development and use of ventricular assist devices and played a major role at Thoratec throughout the history of the company. Howard Chase, who served as a director for more than 20 years, provided great counsel and support as the company became a leader in treating advanced stage heart failure," Burbach added.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure.
'/>"/>

SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Thoratec Schedules Third Quarter Conference Call, Webcast
2. Thoratecs ITC Division Receives FDA Warning Letter
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
5. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
6. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
7. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
8. Thoratec Presentation at Piper Jaffary Conference to be Webcast
9. Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
10. Thoratec Reports 34 Percent Increase in 2008 Revenues
11. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009).... 4 The National Cancer Institute ...t to Fred Hutchinson Cancer Research Center to bec...mation Service Contact Center. ,, The move will...rly tripling the size of its current CIS workforce...al, which is scheduled for March 15, 2010. The Sea...
(Date:12/4/2009)...-- Substantial progress has been made over the las...o diagnose and treat epilepsy and its complication...ot reached most of the 50 million people around th...n people in the United States who have the disorde...sident of the American Epilepsy Society (AES), the...
(Date:12/4/2009)...obby Berk Home & Author and Political Analyst ...oy Drive benefiting Providence Hospital’s &l...The goal is to raise $5000 in cash and toy donatio...obby Berk Home will match the donation. Toys will ... at Providence Hospital. , ...
(Date:12/4/2009)...lear enough to recommend its use, experts say , ,...ncer patients, glaucoma patients and others can be...is shows that it can help multiple sclerosis (MS) ...re the hallmark of the debilitating autoimmune dis...ids in MS appears to be comprehensive, and should ...
(Date:12/4/2009)...Calif., Dec. 4 Genomic H...the company will present results from five studies...osium (SABCS), taking place December 9-13, 2009, a...f the studies analyze Onco type DX®, the com...currently use to predict the likelihood of chemoth...
Breaking Medicine News(10 mins):Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4
...reWorks Makes Fast 50 List Three Years Running and...venue Growth, ATLANTA, Sept. 28 For the third ye...ding Managed Security Services,Providers (MSSP), h...ue growth from 2002-2006 and has ranked in the top...
...ZEMAN, Mont. -- Stable flies are the latest suspec...hs of hundreds of pelican chicks at the Medicine L... West Nile virus killed 800 to 1,000 pelican chick...rsity said earlier this year that he considered th...
...0-mile fundraising journey nearing completion, SA...ter,60, will triumphantly finish a five-month 2,20...ge at 4:45 p.m. Saturday, Oct. 6, in San Francisco...lly disabled son, Nathan, for nearly 19 years. Am...
... that helps them appreciate another,s discomfort s...ay News) -- Doctors are able to switch off the par...in patients experience during treatment, and inste... on patients while treating them, doctors have to ...
...AGO, Sept. 28 U.S. Environmental,Protection Agenc...rict 64,that follow-up sampling done at the Carpen...ber shows no PCB risk to students, faculty or staf...mples were taken as a precaution because PCBs were...
...viduals and Families can immediately download a fr...he cost of common prescription drugs, WHEATON, Il...cated in,Wheaton, Illinois today announced the lau...ing free personalized,prescription drug discount c...
Other Medicine News:Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 2Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 3Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 4Health News:Montana State University researchers investigate new suspect in West Nile deaths of pelicans 2Health News:Man Walking to California for Son Approaching Finish Line 2Health News:Brain 'Switch' Helps Doctors Deal With Patients' Pain 2Health News:EPA Says Follow-Up Sampling Shows No PCB Risk at Park Ridge Elementary School 2Health News:Free Prescription Drug Program Uses Internet to Deliver Cards - Offers Assistance to Uninsured 2
(Date:12/3/2009)..., THOUSAND OAKS, Calif., Dec. 3 /PRNewswire-Fir...udents from across the United States (U.S.) and Eu...gain hands-on laboratory experience under renowned...es. Now, the Amgen Scholars - past, present and f...mgen Scholars Community at www.amgenscholars.com ...
(Date:12/3/2009)... , PISCATAWAY, N.J., Dec. 3 /PRNewswire-FirstC...ard: MLSS), the recognized leader in advanced inje...tered into a joint venture with China National Med...chang Humanwell Pharmaceutical Co. Ltd., both inco...RC"), to develop orthopedic and epidural drug deli...
(Date:12/3/2009)... , WALTHAM, Mass., Dec. 3 D...arch and advisory firms focusing on pharmaceutical...diabetes drug market in Brazil will grow from $417...ected 15 percent annual growth rate is attributed ..., increased use of new generation antidiabetics su...
Breaking Medicine Technology:New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3A new scan for lung diseases 59354 1A new scan for lung diseases 59354 2Blood vessel builders 10333 1Blood vessel builders 10333 2Dogs Helping to Advance Cancer Research 59351 1Dogs Helping to Advance Cancer Research 59351 2
...ciences From University of Cambridge -...MBRIDGE, England, Oct. 24 Stem Cell Sciences plc,...mmercialisation of stem,cells and stem cell techno...for reprogramming adult mammalian cells into authe... published in PLoS Biology, the peer-reviewed,scie...
...uppository Represents an Important Development in ...s Alternative for Effective,Insulin Delivery, Ora.../www.oramed.com ), a,developer of alternative drug...eived approval from the South Africa Medicines Con...ials on eight healthy human volunteers for ORMD,08...
Other Medicine Technology:Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 2Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository 2Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository 3
ECTRA II System without Endoscope
AZTEC Shoulder Holder and MITT
Teardrop punch, Right
Meniscus Screw
Medicine Products: